BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29308530)

  • 1. The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study.
    Verschoor AJ; Bovée JVMG; Overbeek LIH; ; Hogendoorn PCW; Gelderblom H
    Virchows Arch; 2018 Feb; 472(2):221-229. PubMed ID: 29308530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.
    Goettsch WG; Bos SD; Breekveldt-Postma N; Casparie M; Herings RM; Hogendoorn PC
    Eur J Cancer; 2005 Dec; 41(18):2868-72. PubMed ID: 16293410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours.
    Barrios CH; Blackstein ME; Blay JY; Casali PG; Chacon M; Gu J; Kang YK; Nishida T; Purkayastha D; Woodman RC; Reichardt P
    Eur J Cancer; 2015 Nov; 51(16):2423-33. PubMed ID: 26248685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era.
    van der Graaf WTA; Tielen R; Bonenkamp JJ; Lemmens V; Verhoeven RHA; de Wilt JHW
    Br J Surg; 2018 Jul; 105(8):1020-1027. PubMed ID: 29664995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour.
    Wong NA; Campbell F; Shepherd NA
    Histopathology; 2015 Jun; 66(7):974-81. PubMed ID: 25346074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.
    Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA
    Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
    Patrikidou A; Domont J; Chabaud S; Ray-Coquard I; Coindre JM; Bui-Nguyen B; Adenis A; Rios M; Bertucci F; Duffaud F; Chevreau C; Cupissol D; Pérol D; Emile JF; Blay JY; Le Cesne A;
    Eur J Cancer; 2016 Jan; 52():173-80. PubMed ID: 26687836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study.
    Verschoor AJ; Bovée JVMG; Mastboom MJL; Sander Dijkstra PD; Van De Sande MAJ; Gelderblom H
    Acta Orthop; 2018 Oct; 89(5):570-574. PubMed ID: 29987945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades.
    Sandvik OM; Søreide K; Kvaløy JT; Gudlaugsson E; Søreide JA
    Cancer Epidemiol; 2011 Dec; 35(6):515-20. PubMed ID: 21489899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and centralization of chordoma in the Netherlands: A nationwide study between 1991 and 2020.
    Lipplaa A; van der Wal RJP; Krol ADG; Peul WC; Bovée JVMG; Gelderblom H
    Cancer Epidemiol; 2024 Apr; 89():102527. PubMed ID: 38277716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
    Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
    Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.